Aevitas Pharmagro Tech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.16 M
as on 24-10-2024
- Company Age 38 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.35 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.00 M
as on 24-10-2024
- Revenue 52.27%
(FY 2023)
- Profit 228.32%
(FY 2023)
- Ebitda 215.63%
(FY 2023)
- Net Worth 413.43%
(FY 2023)
- Total Assets 14.85%
(FY 2023)
About Aevitas Pharmagro Tech
The Corporate was formerly known as Pipecon Conslutants (India) Pvt Ltd. The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.16 M.
The company currently has active open charges totaling ₹4.35 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ningileri Balraj and Deepti Mahajan serve as directors at the Company.
- CIN/LLPIN
U74140MH1986PTC039607
- Company No.
039607
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 1986
- Date of AGM
18 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aevitas Pharmagro Tech Private Limited offer?
Aevitas Pharmagro Tech Private Limited offers a wide range of products and services, including Project Management, Construction Management Services, Turnkey Consultants & Solutions.
Who are the key members and board of directors at Aevitas Pharmagro Tech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ningileri Balraj  | Managing Director | 01-Jul-2009 | Current |
| Deepti Mahajan | Managing Director | 01-Jul-2009 | Current |
Board Members(0)
| Name | Designation | Appointment Date | Status |
|---|
Financial Performance of Aevitas Pharmagro Tech.
Aevitas Pharmagro Tech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.27% increase. The company also saw a substantial improvement in profitability, with a 228.32% increase in profit. The company's net worth Soared by an impressive increase of 413.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aevitas Pharmagro Tech?
In 2023, Aevitas Pharmagro Tech had a promoter holding of 79.99% and a public holding of 20.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Feb 2022 | ₹4.00 M | Open |
Bank Of India Creation Date: 16 Jul 2015 | ₹3.95 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 18 Dec 2014 | ₹0.50 M | Satisfied |
How Many Employees Work at Aevitas Pharmagro Tech?
Aevitas Pharmagro Tech has a workforce of 107 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aevitas Pharmagro Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aevitas Pharmagro Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
